Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-Week Randomised Double-Blind, Placebo-Controlled Study of BCI-540 80 mg q.d. and 80 mg t.i.d. in the Treatment of Adults With Major Depressive Disorder and Concomitant Anxiety

NCT00621270 is registered in ClinicalTrials.gov with BrainCells Inc. as lead sponsor.

NCT NCT00621270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00621270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-Week Randomised Double-Blind, Placebo-Controlled Study of BCI-540 80 mg q.d. and 80 mg t.i.d. in the Treatment of Adults With Major Depressive Disorder and Concomitant Anxiety
Lead sponsor
BrainCells Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2008
Completion date
October 31, 2009
Enrollment
115 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, major depressive disorder